Loading stock…

Establishment Labs Holdings Inc. (ESTA) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Establishment Labs Holdings Inc.

ESTAMarket cap $1.95BPrice $65.3

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes breast implants and body contouring devices, including Motiva, engineered to feel more natural and reduce complications than older silicone designs. It's carved out a growing niche challenging the decades-long duopoly that dominated the global implant market.

In Bastion Portfolios?

52W Return+38%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+9%7

Revenue Forecast

Rev CAGR (1y)+28%9

Rev CAGR (3y)+25%9

Rev CAGR (5y)+24%10

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+20%5

EPS Growth Y+3+1827%10

Quality

Margins

EBIT Margin-8%1

Net Income Margin-16%1

Free Cash Flow Margin-17%2

Debt

Net Debt/EBITDAna–

Efficiency

ROE-175%1

ROA-11%1

Earnings Stabilityna–

GEAR+VERY WEAK13

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)na–

P/E Ratio (Forward 3y)531

P/BV90.11

EV Multiples

EV/EBITDA Fwd1261

EV/EBIT Fwdna–

Yield

Free Cash Flow Yield-2.1%2

Dividend Yieldna–

Momentum

Short term

1 month return-12%2

3 month return-28%1

YTD return-10%3

Mid term

Price vs 52wHigh67%3

1 year return+61%9

Long term

3 year return+60%6

5 year return-12%3

Risk Shield

Price Risk

Beta0.85

Volatility53%3

Free Cash Flow

Free Cash Flow Margin-17%2

Free Cash Flow Yield-2.1%2

Quality

ROCE-7%1

Earnings Stabilityna–

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

ESTAEstablishment Labs Holdings

Revenue FY25$211M

GROWTH RATING↗

VERY STRONG87 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%7

Revenue, next 1Y+28%9

Revenue, next 3Y, CAGR+25%9

Revenue, next 5Y, CAGR+24%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+1827%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 87% of companies worldwide.

Revenue grew 9%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 25%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 9%/yr over the last 3 years and is set to grow 25%/yr from here.

The runway holds up: revenue is set to grow 24%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK21 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-12%2

3-month return-28%1

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return+61%9

3-year return+60%6

5-year return-12%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+60% over three years and -12% over five), roughly average for the market.

It's up 61% over the past year, but 33% below its 52-week high. That is a touch ahead of the market.

WEAKNESSES

The stock is underperforming over the past month (-12%), over three months (-28%) and so far this year (-10%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the stock is underperforming over the past month, over three months and so far this year.

04Value

Are you paying a fair price for it?

Stop guessing on Establishment Labs Holdings Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ESTAEstablishment Labs Holdings

Revenue FY25$211M

GROWTH RATING↗

VERY STRONG87 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+9%7

Revenue, next 1Y+28%9

Revenue, next 3Y, CAGR+25%9

Revenue, next 5Y, CAGR+24%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+1827%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 87% of companies worldwide.

Revenue grew 9%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 25%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 9%/yr over the last 3 years and is set to grow 25%/yr from here.

The runway holds up: revenue is set to grow 24%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK21 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-12%2

3-month return-28%1

YTD return-10%3

MID & LONG-TERM▾SCORE

% of 52-week high67%3

1-year return+61%9

3-year return+60%6

5-year return-12%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

Average long-term results. Multi-year returns are middling (+60% over three years and -12% over five), roughly average for the market.

It's up 61% over the past year, but 33% below its 52-week high. That is a touch ahead of the market.

WEAKNESSES

The stock is underperforming over the past month (-12%), over three months (-28%) and so far this year (-10%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Establishment Labs Holdings Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community